Products
Online Inquiry
Our Products Cannot Be Used As Medicines Directly For Personal Use.
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
Sunitinib Malate (Sutent)
Cat No.
CEI-0011
Description
Sunitinib Malate (Sutent) can inhibit VEGFR2 (Flk-1) and PDGFRbeta with IC50 of 80 nM and 2 nM.
Alias
SU-11248
CAS No.
341031-54-7
Molecular Weight
532.56
Purity
>99%
Storage
2 years at -20 centigrade
Synonyms
SU-11248
Targets
VEGFR2, PDGFRbeta
Molecular Formula
C22H27FN4O2.C4H6O5
Chemical Name
(Z)-N-(2-(diethylamino)ethyl)-5-((5-fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide,(S)-2-hydroxysuccinic acid
Solubility
DSMO 5 mg/mL Water
In vitro
By competing with ATP for binding within the intracellular domain of various wild-type and/or mutated receptor tyrosine kinases, sunitinib (SU11248) inhibit a list of tyrosine kinase including endothelial growth factor receptors (VEGFR-1, VEGFR-2, and VEGFR-3), platelet-derived growth factor receptors (PDGFR-alpha and PDGFR- beta ), fms-related tyrosine kinase 3 (FLT3), stem cell growth factor receptor KIT, and RET. As a multitargeted agent, sunitinib achieves a broader spectrum of activity than single-target agents including erlotinib and gefitinib. Sunitinib shows great inhibition to many cancer cells including gastrointestinal stromal tumours (GIST) and renal-cell carcinoma (RCC).
Download
Download Datasheet